These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 25428709)

  • 61. Shared Behavioral and Neurocircuitry Disruptions in Drug Addiction, Obesity, and Binge Eating Disorder: Focus on Group I mGluRs in the Mesolimbic Dopamine Pathway.
    Yohn SE; Galbraith J; Calipari ES; Conn PJ
    ACS Chem Neurosci; 2019 May; 10(5):2125-2143. PubMed ID: 30933466
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Binge eating in pre-clinical models.
    Rospond B; Szpigiel J; Sadakierska-Chudy A; Filip M
    Pharmacol Rep; 2015 Jun; 67(3):504-12. PubMed ID: 25933962
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The overlap between binge eating disorder and substance use disorders: Diagnosis and neurobiology.
    Schreiber LR; Odlaug BL; Grant JE
    J Behav Addict; 2013 Dec; 2(4):191-8. PubMed ID: 25215200
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Marketing Messages in Continuing Medical Education (CME) Modules on Binge-Eating Disorder (BED).
    Jung J; Fugh-Berman A
    J Am Board Fam Med; 2020; 33(2):240-251. PubMed ID: 32179607
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Neuroendocrinological factors in binge eating disorder: A narrative review.
    Baenas I; Miranda-Olivos R; Solé-Morata N; Jiménez-Murcia S; Fernández-Aranda F
    Psychoneuroendocrinology; 2023 Apr; 150():106030. PubMed ID: 36709632
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Unravelling the role and mechanism of adipokine and gastrointestinal signals in animal models in the nonhomeostatic control of energy homeostasis: Implications for binge eating disorder.
    Novelle MG; Diéguez C
    Eur Eat Disord Rev; 2018 Nov; 26(6):551-568. PubMed ID: 30280451
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Genetics factors in pathogenesis and clinical genetics of binge eating disorder].
    Kibitov АО; Мazo GE
    Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(7):113-119. PubMed ID: 28635940
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Binge Eating Disorder: A 5-Year Retrospective Study on Experimental Drugs.
    Levitan MN; Papelbaum M; Carta MG; Appolinario JC; Nardi AE
    J Exp Pharmacol; 2021; 13():33-47. PubMed ID: 33542663
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Pimavanserin and Lorcaserin Attenuate Measures of Binge Eating in Male Sprague-Dawley Rats.
    Price AE; Brehm VD; Hommel JD; Anastasio NC; Cunningham KA
    Front Pharmacol; 2018; 9():1424. PubMed ID: 30581386
    [TBL] [Abstract][Full Text] [Related]  

  • 70. An exploratory machine learning approach to identify placebo responders in pharmacological binge eating disorder trials.
    Goyal RK; Kalaria SN; McElroy SL; Gopalakrishnan M
    Clin Transl Sci; 2022 Dec; 15(12):2878-2887. PubMed ID: 36126231
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Disgust sensitivity and behavioural inhibitory systems in binge eating disorder: associations with eating pathology.
    Brassard SL; Laliberte M; MacKillop J; Balodis IM
    Eat Weight Disord; 2023 Feb; 28(1):15. PubMed ID: 36805341
    [TBL] [Abstract][Full Text] [Related]  

  • 72. 1-Boc-Piperidine-4-Carboxaldehyde Prevents Binge-Eating Behaviour and Anxiety in Rats.
    Guzmán-Rodríguez S; Chávez-Reyes J; Vázquez-León P; Soriano-Ursúa MA; Rosalez MN; Allende G; Marichal-Cancino BA
    Pharmacology; 2021; 106(5-6):305-315. PubMed ID: 33756489
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Mapping the landscape and structure of global research on binge eating disorder: Visualization and bibliometric analysis.
    Zyoud SH; Shakhshir M; Abushanab AS; Koni A; Shahwan M; Jairoun AA; Al-Jabi SW
    World J Psychiatry; 2022 Jul; 12(7):982-994. PubMed ID: 36051594
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Delineating the role of binge eating in cancer research.
    Mason TB; Smith KE
    Eat Weight Disord; 2021 Oct; 26(7):2109-2116. PubMed ID: 33201393
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The pharmacological options in the treatment of eating disorders.
    Milano W; De Rosa M; Milano L; Riccio A; Sanseverino B; Capasso A
    ISRN Pharmacol; 2013; 2013():352865. PubMed ID: 23956871
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Pharmacological management of binge eating disorder: current and emerging treatment options.
    McElroy SL; Guerdjikova AI; Mori N; O'Melia AM
    Ther Clin Risk Manag; 2012; 8():219-41. PubMed ID: 22654518
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Insights revealed by rodent models of sugar binge eating.
    Murray SM; Tulloch AJ; Chen EY; Avena NM
    CNS Spectr; 2015 Dec; 20(6):530-6. PubMed ID: 26510689
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Obesogenic Behavior and Binge Eating Disorder in an Elderly Female with Schizophrenia.
    Veeraraghavan V
    J Obes Metab Syndr; 2021 Jun; 30(2):184-187. PubMed ID: 33820877
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Genetic aspects of binge eating disorder Part 2. Molecular genetics and pharmacogenetic approaches].
    Kibitov АО; Мazo GE
    Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(8):102-108. PubMed ID: 28635745
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Editorial: Eating Disorders From Binge to Anorexia: Basic and Clinical Approaches for a Translational Research.
    Tolle V; Viltart O
    Front Nutr; 2021; 8():678451. PubMed ID: 34055862
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.